Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Clinical trial NCT04742595 · COMPLETED

Trial details

NCT number: NCT04742595
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Symptomatic COVID-19 Infection Laboratory-Confirmed

Start date: 2020-12-18
Primary completion: 2024-09-20
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.